VENUSREM Q1 FY27 results at a glance
VENUS REMEDIES LIMITED Q1 FY27 key results metrics| Quarter | Q1 FY27 |
|---|
| Quarter ended | 30 Jun 2026 |
|---|
| Revenue | ₹179 cr |
|---|
| Revenue YoY | +30.4% |
|---|
| Operating profit | ₹27.42 cr |
|---|
| Operating margin | 15.3% |
|---|
| Net profit | ₹22.97 cr |
|---|
| Net profit YoY | +139.3% |
|---|
| Net profit QoQ | -51.6% |
|---|
| Net margin | 12.8% |
|---|
| Basic EPS | ₹17.18 |
|---|
| TTM revenue | ₹811 cr |
|---|
| TTM net profit | ₹116 cr |
|---|
| TTM net margin | 14.3% |
|---|
VENUSREM Q1 FY27 results: what the numbers say
VENUS REMEDIES LIMITED (VENUSREM) has reported its Q1 FY27 results for the quarter ended 2026-06-30. The company posted revenue of ₹179 cr and a net profit of ₹22.97 cr, translating into earnings per share of ₹17.18.
Compared with the same quarter a year earlier, revenue grew strongly by +30.4% and net profit grew sharply by +139.3%. Profit rising faster than revenue points to better cost control or operating leverage flowing through the P&L.
Operating profit for the quarter stood at ₹27.42 cr, an operating margin of 15.3% versus 6.7% a year ago — a gain of 8.6 percentage points.
VENUSREM quarter-wise results table
Net profit
₹22.97 cr
+139.3% YoY
Operating profit
₹27.42 cr
+198.0% YoY
VENUS REMEDIES LIMITED (VENUSREM) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q1 FY272026-06-30 | ₹179 cr | ₹27.42 cr | ₹22.97 cr | 15.3% | 12.8% | ₹17.18 | +139.3% | -51.6% |
| Q4 FY262026-03-31 | ₹259 cr | ₹56.66 cr | ₹47.49 cr | 21.8% | 18.3% | ₹35.53 | — | +85.7% |
| Q3 FY262025-12-31 | ₹180 cr | ₹30.96 cr | ₹25.58 cr | 17.2% | 14.2% | ₹19.14 | — | +27.1% |
| Q2 FY262025-09-30 | ₹193 cr | ₹24.79 cr | ₹20.13 cr | 12.9% | 10.4% | ₹15.06 | — | +109.7% |
| Q1 FY262025-06-30 | ₹137 cr | ₹9.2 cr | ₹9.6 cr | 6.7% | 7.0% | ₹7.18 | — | — |
| TTM (last 4 quarters) | ₹811 cr | ₹140 cr | ₹116 cr | 17.2% | 14.3% | ₹86.91 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
VENUSREM quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
VENUS REMEDIES LIMITED quarterly income statement| Particulars | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q2 FY262025-09-30 | Q1 FY262025-06-30 |
|---|
| Revenue / Sales | ₹179 cr | ₹259 cr | ₹180 cr | ₹193 cr | ₹137 cr |
|---|
| Total expenses | ₹151 cr | ₹203 cr | ₹149 cr | ₹168 cr | ₹128 cr |
|---|
| Gross profit | ₹94.58 cr | ₹140 cr | ₹94.01 cr | ₹85.44 cr | ₹63.03 cr |
|---|
| Operating profit (EBIT) | ₹27.42 cr | ₹56.66 cr | ₹30.96 cr | ₹24.79 cr | ₹9.2 cr |
|---|
| Operating margin | 15.3% | 21.8% | 17.2% | 12.9% | 6.7% |
|---|
| Interest cost | ₹0 cr | ₹0.01 cr | ₹0.01 cr | ₹0.01 cr | ₹0.01 cr |
|---|
| Profit before tax | ₹30.04 cr | ₹61.61 cr | ₹33.47 cr | ₹26.49 cr | ₹12.6 cr |
|---|
| Tax expense | ₹7.07 cr | ₹14.11 cr | ₹7.89 cr | ₹6.36 cr | ₹3.01 cr |
|---|
| Effective tax rate | 23.5% | 22.9% | 23.6% | 24.0% | 23.9% |
|---|
| Net profit (PAT) | ₹22.97 cr | ₹47.49 cr | ₹25.58 cr | ₹20.13 cr | ₹9.6 cr |
|---|
| Net profit margin | 12.8% | 18.3% | 14.2% | 10.4% | 7.0% |
|---|
| Basic EPS | ₹17.18 | ₹35.53 | ₹19.14 | ₹15.06 | ₹7.18 |
|---|
| Diluted EPS | ₹17.18 | ₹35.53 | ₹19.14 | ₹15.06 | ₹7.18 |
|---|
VENUSREM results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|
| Revenue YoY | +30.4% | — | — | — | — |
|---|
| Revenue QoQ | -31.0% | +43.9% | -6.5% | +40.5% | — |
|---|
| Operating profit YoY | +198.0% | — | — | — | — |
|---|
| Operating profit QoQ | -51.6% | +83.0% | +24.9% | +169.5% | — |
|---|
| Net profit YoY | +139.3% | — | — | — | — |
|---|
| Net profit QoQ | -51.6% | +85.7% | +27.1% | +109.7% | — |
|---|
| EPS YoY | +139.3% | — | — | — | — |
|---|
| EPS QoQ | -51.6% | +85.6% | +27.1% | +109.7% | — |
|---|
VENUSREM annual results history
Full-year performance for VENUS REMEDIES LIMITED, useful for reading each quarter in context.
VENUS REMEDIES LIMITED annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹735 cr | ₹647 cr | ₹591 cr | ₹553 cr |
|---|
| Total expenses | ₹628 cr | ₹606 cr | ₹558 cr | ₹526 cr |
|---|
| Gross profit | ₹318 cr | ₹245 cr | ₹218 cr | ₹208 cr |
|---|
| Operating profit (EBIT) | ₹107 cr | ₹41.02 cr | ₹33.16 cr | ₹27.73 cr |
|---|
| Operating margin | 14.5% | 6.3% | 5.6% | 5.0% |
|---|
| Interest cost | ₹0.04 cr | ₹0.07 cr | ₹0.09 cr | ₹0.12 cr |
|---|
| Profit before tax | ₹134 cr | ₹71.83 cr | ₹44.64 cr | ₹37.93 cr |
|---|
| Tax expense | ₹31.36 cr | ₹26.51 cr | ₹16.15 cr | ₹11.36 cr |
|---|
| Effective tax rate | 23.4% | 36.9% | 36.2% | 30.0% |
|---|
| Net profit (PAT) | ₹103 cr | ₹45.31 cr | ₹28.49 cr | ₹26.57 cr |
|---|
| Net profit margin | 14.0% | 7.0% | 4.8% | 4.8% |
|---|
| Basic EPS | ₹76.90 | ₹33.90 | ₹21.31 | ₹19.88 |
|---|
| Diluted EPS | ₹76.90 | ₹33.90 | ₹21.31 | ₹19.88 |
|---|
Revenue trend and demand read-through
Topline for Q1 FY27 came in at ₹179 cr against ₹137 cr in Q1 FY26, and ₹259 cr in the preceding Q4 FY26 quarter.
On a sequential basis revenue declined -31.0%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹151 cr, or 84.7% of revenue, with operating profit grew +198.0% year on year.
Margins, tax and profitability
Net profit of ₹22.97 cr works out to a net margin of 12.8% compared with 7.0% in the year-ago quarter. Margin expansion of this kind usually reflects a better product or service mix, softer input costs, or tighter overheads.
Below the operating line, VENUS REMEDIES LIMITED reported profit before tax of ₹30.04 cr, a tax charge of ₹7.07 cr (effective rate 23.5%), interest cost of ₹0 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹47.49 cr in Q4 FY26 to ₹22.97 cr in Q1 FY27, a change of -51.6%.
Trailing twelve months and annual context
Across the trailing four quarters VENUS REMEDIES LIMITED has generated revenue of ₹811 cr and net profit of ₹116 cr, a trailing net margin of 14.3%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹735 cr with net profit of ₹103 cr and EPS of ₹76.90, versus the prior year where revenue grew +13.5% and profit grew +126.8%.
What to watch in the next VENUSREM quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A sustained run of year-on-year profit growth is what usually drives a re-rating rather than any single quarter.
VENUS REMEDIES LIMITED has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
VENUSREM results coverage
No results report published for VENUSREM yet — our desk covers each quarter within minutes of the filing.
VENUSREM quarterly results FAQs
What were VENUS REMEDIES LIMITED (VENUSREM) Q1 FY27 results?
In Q1 FY27 (quarter ended 30 Jun 2026), VENUS REMEDIES LIMITED reported revenue of ₹179 cr and net profit of ₹22.97 cr, a change of +139.3% year on year on +30.4% revenue growth. EPS stood at ₹17.18.
What is VENUSREM profit margin in Q1 FY27?
VENUS REMEDIES LIMITED posted a net profit margin of 12.8% and an operating margin of 15.3% in Q1 FY27. On a trailing twelve-month basis, revenue is ₹811 cr and net profit ₹116 cr.
Did VENUSREM results beat the previous quarter?
VENUS REMEDIES LIMITED net profit changed -51.6% quarter on quarter, from ₹47.49 cr in Q4 FY26 to ₹22.97 cr in Q1 FY27.
When are VENUS REMEDIES LIMITED (VENUSREM) quarterly results?
VENUS REMEDIES LIMITED has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see VENUSREM latest quarterly results?
Results coverage for VENUSREM will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the VENUSREM stock page.
What is VENUS REMEDIES LIMITED annual revenue and profit?
For FY26, VENUS REMEDIES LIMITED reported full-year revenue of ₹735 cr and net profit of ₹103 cr, with EPS of ₹76.90.
How many quarterly results has VENUSREM declared recently?
Past results dates for VENUSREM will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 12 Sept 2026. For information only, not investment advice.
